Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease

Recent World Health Organization guidance has aimed to provide pragmatic guidance acknowledging the role of sequential nasopharyngeal swabs taken >24 hours apart for SARS‐CoV‐2 in high‐risk populations. Patients with chronic kidney disease (CKD) are known to have an altered immune milieu which ma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology (Carlton, Vic.) Vic.), 2021-04, Vol.26 (4), p.328-332
Hauptverfasser: O'Sullivan, Eoin D., Lees, Jennifer S., Howie, Katie L., Pugh, Dan, Gillis, Keith A., Traynor, Jamie P., Macintyre, Iain, Mark, Patrick B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 332
container_issue 4
container_start_page 328
container_title Nephrology (Carlton, Vic.)
container_volume 26
creator O'Sullivan, Eoin D.
Lees, Jennifer S.
Howie, Katie L.
Pugh, Dan
Gillis, Keith A.
Traynor, Jamie P.
Macintyre, Iain
Mark, Patrick B.
description Recent World Health Organization guidance has aimed to provide pragmatic guidance acknowledging the role of sequential nasopharyngeal swabs taken >24 hours apart for SARS‐CoV‐2 in high‐risk populations. Patients with chronic kidney disease (CKD) are known to have an altered immune milieu which may be associated with a delay in viral clearance. Here, a cross‐sectional observational study of 138 patients admitted with SARS‐CoV‐2 infection at two large regional hospitals in Scotland, UK examined the median time to two consecutive negative nasopharyngeal swabs for SARS‐CoV‐2 in an inpatient population. The median time from admission to the first of two consecutive negative nasopharyngeal swabs was 18 days (range = 1‐44) in patients with CKD, compared with 11 days (range: 1‐71) in patients without CKD (P = .0007). Multivariable linear regression analysis using explanatory variables of age, sex, SARS‐CoV‐2 disease severity, key comorbidities and renal function showed that declining estimated glomerular filtration rate was independently associated with prolonged time to viral clearance. Our data suggest that patients with CKD who are admitted to hospital with SARS‐CoV‐2 take longer to achieve sequential negative nasopharyngeal swab reverse transcription‐polymerase chain reaction results than those without CKD. This has implications for renal service provision, discharge planning and hospital capacity as well as a direct impact on patients due to extended hospital stay, anxiety and stigmatisation. SUMMARY AT A GLANCE In this study, the authors investigated the time between admissions to SARS‐CoV‐2 virus‐negative nasopharyngeal swabs in inpatients. They found that CKD patients had longer time to viral clearance than non‐CKD patients, and concluded that longer CKD patients had longer time to viral clearance, affecting renal service delivery, discharge planning, and admission capacity. In addition, potential anxiety and stigma have a direct impact on the patient.
doi_str_mv 10.1111/nep.13844
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2473409771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473409771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4164-1ea8ab2183b16a71f98654c10de0fb5efdafc38f8397054d601bae4d85c10a943</originalsourceid><addsrcrecordid>eNp10LtOwzAUBmALgSgUBl4AWWKBIcWO7dgZUVUuEgLEbY2c-KQ1pE6xW6puPALPyJNgaGFAwsPxGT79OvoR2qOkR-M7djDpUaY4X0NblHOSUJnL9bizlCSCCdVB2yE8EUJlmtFN1GGMZUrl6Ra6vvFt07ohGHx3cnv38fbebx_jTPGr9brBYQTGWDfE1uGJnlpw04DndjrC1ci3zlb42RoHC2xsAB1gB23Uugmwu_q76OF0cN8_Ty6vzy76J5dJxWnGEwpa6TKlipU005LWucoErygxQOpSQG10XTFVK5ZLIrjJCC01cKNENDrnrIsOl7kT377MIEyLsQ0VNI120M5CkXLJOMmlpJEe_KFP7cy7eF1UeS5EJqSK6mipKt-G4KEuJt6OtV8UlBRfLRex5eK75Wj3V4mzcgzmV_7UGsHxEsxtA4v_k4qrwc0y8hP6s4bj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2499556578</pqid></control><display><type>article</type><title>Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>O'Sullivan, Eoin D. ; Lees, Jennifer S. ; Howie, Katie L. ; Pugh, Dan ; Gillis, Keith A. ; Traynor, Jamie P. ; Macintyre, Iain ; Mark, Patrick B.</creator><creatorcontrib>O'Sullivan, Eoin D. ; Lees, Jennifer S. ; Howie, Katie L. ; Pugh, Dan ; Gillis, Keith A. ; Traynor, Jamie P. ; Macintyre, Iain ; Mark, Patrick B.</creatorcontrib><description>Recent World Health Organization guidance has aimed to provide pragmatic guidance acknowledging the role of sequential nasopharyngeal swabs taken &gt;24 hours apart for SARS‐CoV‐2 in high‐risk populations. Patients with chronic kidney disease (CKD) are known to have an altered immune milieu which may be associated with a delay in viral clearance. Here, a cross‐sectional observational study of 138 patients admitted with SARS‐CoV‐2 infection at two large regional hospitals in Scotland, UK examined the median time to two consecutive negative nasopharyngeal swabs for SARS‐CoV‐2 in an inpatient population. The median time from admission to the first of two consecutive negative nasopharyngeal swabs was 18 days (range = 1‐44) in patients with CKD, compared with 11 days (range: 1‐71) in patients without CKD (P = .0007). Multivariable linear regression analysis using explanatory variables of age, sex, SARS‐CoV‐2 disease severity, key comorbidities and renal function showed that declining estimated glomerular filtration rate was independently associated with prolonged time to viral clearance. Our data suggest that patients with CKD who are admitted to hospital with SARS‐CoV‐2 take longer to achieve sequential negative nasopharyngeal swab reverse transcription‐polymerase chain reaction results than those without CKD. This has implications for renal service provision, discharge planning and hospital capacity as well as a direct impact on patients due to extended hospital stay, anxiety and stigmatisation. SUMMARY AT A GLANCE In this study, the authors investigated the time between admissions to SARS‐CoV‐2 virus‐negative nasopharyngeal swabs in inpatients. They found that CKD patients had longer time to viral clearance than non‐CKD patients, and concluded that longer CKD patients had longer time to viral clearance, affecting renal service delivery, discharge planning, and admission capacity. In addition, potential anxiety and stigma have a direct impact on the patient.</description><identifier>ISSN: 1320-5358</identifier><identifier>EISSN: 1440-1797</identifier><identifier>DOI: 10.1111/nep.13844</identifier><identifier>PMID: 33368892</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Aged ; Aged, 80 and over ; CKD ; COVID-19 - complications ; COVID-19 - diagnosis ; COVID-19 - therapy ; COVID-19 Nucleic Acid Testing ; Cross-Sectional Studies ; Female ; Glomerular Filtration Rate ; Hospitalization ; Humans ; Immune clearance ; Kidney diseases ; Linear Models ; Male ; Middle Aged ; Patients ; Polymerase chain reaction ; Renal function ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - therapy ; Renal Insufficiency, Chronic - virology ; Reverse Transcriptase Polymerase Chain Reaction ; Reverse transcription ; SARS-CoV-2 - physiology ; SARS‐CoV‐2 ; Scotland ; Severe acute respiratory syndrome coronavirus 2 ; Time Factors ; viral shedding ; Virus Shedding</subject><ispartof>Nephrology (Carlton, Vic.), 2021-04, Vol.26 (4), p.328-332</ispartof><rights>2020 Asian Pacific Society of Nephrology</rights><rights>2020 Asian Pacific Society of Nephrology.</rights><rights>2021 Asian Pacific Society of Nephrology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4164-1ea8ab2183b16a71f98654c10de0fb5efdafc38f8397054d601bae4d85c10a943</citedby><cites>FETCH-LOGICAL-c4164-1ea8ab2183b16a71f98654c10de0fb5efdafc38f8397054d601bae4d85c10a943</cites><orcidid>0000-0002-7709-6595 ; 0000-0003-3387-2123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnep.13844$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnep.13844$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33368892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Sullivan, Eoin D.</creatorcontrib><creatorcontrib>Lees, Jennifer S.</creatorcontrib><creatorcontrib>Howie, Katie L.</creatorcontrib><creatorcontrib>Pugh, Dan</creatorcontrib><creatorcontrib>Gillis, Keith A.</creatorcontrib><creatorcontrib>Traynor, Jamie P.</creatorcontrib><creatorcontrib>Macintyre, Iain</creatorcontrib><creatorcontrib>Mark, Patrick B.</creatorcontrib><title>Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease</title><title>Nephrology (Carlton, Vic.)</title><addtitle>Nephrology (Carlton)</addtitle><description>Recent World Health Organization guidance has aimed to provide pragmatic guidance acknowledging the role of sequential nasopharyngeal swabs taken &gt;24 hours apart for SARS‐CoV‐2 in high‐risk populations. Patients with chronic kidney disease (CKD) are known to have an altered immune milieu which may be associated with a delay in viral clearance. Here, a cross‐sectional observational study of 138 patients admitted with SARS‐CoV‐2 infection at two large regional hospitals in Scotland, UK examined the median time to two consecutive negative nasopharyngeal swabs for SARS‐CoV‐2 in an inpatient population. The median time from admission to the first of two consecutive negative nasopharyngeal swabs was 18 days (range = 1‐44) in patients with CKD, compared with 11 days (range: 1‐71) in patients without CKD (P = .0007). Multivariable linear regression analysis using explanatory variables of age, sex, SARS‐CoV‐2 disease severity, key comorbidities and renal function showed that declining estimated glomerular filtration rate was independently associated with prolonged time to viral clearance. Our data suggest that patients with CKD who are admitted to hospital with SARS‐CoV‐2 take longer to achieve sequential negative nasopharyngeal swab reverse transcription‐polymerase chain reaction results than those without CKD. This has implications for renal service provision, discharge planning and hospital capacity as well as a direct impact on patients due to extended hospital stay, anxiety and stigmatisation. SUMMARY AT A GLANCE In this study, the authors investigated the time between admissions to SARS‐CoV‐2 virus‐negative nasopharyngeal swabs in inpatients. They found that CKD patients had longer time to viral clearance than non‐CKD patients, and concluded that longer CKD patients had longer time to viral clearance, affecting renal service delivery, discharge planning, and admission capacity. In addition, potential anxiety and stigma have a direct impact on the patient.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>CKD</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - therapy</subject><subject>COVID-19 Nucleic Acid Testing</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Glomerular Filtration Rate</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Immune clearance</subject><subject>Kidney diseases</subject><subject>Linear Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Polymerase chain reaction</subject><subject>Renal function</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Renal Insufficiency, Chronic - virology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Reverse transcription</subject><subject>SARS-CoV-2 - physiology</subject><subject>SARS‐CoV‐2</subject><subject>Scotland</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Time Factors</subject><subject>viral shedding</subject><subject>Virus Shedding</subject><issn>1320-5358</issn><issn>1440-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10LtOwzAUBmALgSgUBl4AWWKBIcWO7dgZUVUuEgLEbY2c-KQ1pE6xW6puPALPyJNgaGFAwsPxGT79OvoR2qOkR-M7djDpUaY4X0NblHOSUJnL9bizlCSCCdVB2yE8EUJlmtFN1GGMZUrl6Ra6vvFt07ohGHx3cnv38fbebx_jTPGr9brBYQTGWDfE1uGJnlpw04DndjrC1ci3zlb42RoHC2xsAB1gB23Uugmwu_q76OF0cN8_Ty6vzy76J5dJxWnGEwpa6TKlipU005LWucoErygxQOpSQG10XTFVK5ZLIrjJCC01cKNENDrnrIsOl7kT377MIEyLsQ0VNI120M5CkXLJOMmlpJEe_KFP7cy7eF1UeS5EJqSK6mipKt-G4KEuJt6OtV8UlBRfLRex5eK75Wj3V4mzcgzmV_7UGsHxEsxtA4v_k4qrwc0y8hP6s4bj</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>O'Sullivan, Eoin D.</creator><creator>Lees, Jennifer S.</creator><creator>Howie, Katie L.</creator><creator>Pugh, Dan</creator><creator>Gillis, Keith A.</creator><creator>Traynor, Jamie P.</creator><creator>Macintyre, Iain</creator><creator>Mark, Patrick B.</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7709-6595</orcidid><orcidid>https://orcid.org/0000-0003-3387-2123</orcidid></search><sort><creationdate>202104</creationdate><title>Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease</title><author>O'Sullivan, Eoin D. ; Lees, Jennifer S. ; Howie, Katie L. ; Pugh, Dan ; Gillis, Keith A. ; Traynor, Jamie P. ; Macintyre, Iain ; Mark, Patrick B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4164-1ea8ab2183b16a71f98654c10de0fb5efdafc38f8397054d601bae4d85c10a943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>CKD</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - therapy</topic><topic>COVID-19 Nucleic Acid Testing</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Glomerular Filtration Rate</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Immune clearance</topic><topic>Kidney diseases</topic><topic>Linear Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Polymerase chain reaction</topic><topic>Renal function</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Renal Insufficiency, Chronic - virology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Reverse transcription</topic><topic>SARS-CoV-2 - physiology</topic><topic>SARS‐CoV‐2</topic><topic>Scotland</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Time Factors</topic><topic>viral shedding</topic><topic>Virus Shedding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Sullivan, Eoin D.</creatorcontrib><creatorcontrib>Lees, Jennifer S.</creatorcontrib><creatorcontrib>Howie, Katie L.</creatorcontrib><creatorcontrib>Pugh, Dan</creatorcontrib><creatorcontrib>Gillis, Keith A.</creatorcontrib><creatorcontrib>Traynor, Jamie P.</creatorcontrib><creatorcontrib>Macintyre, Iain</creatorcontrib><creatorcontrib>Mark, Patrick B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Sullivan, Eoin D.</au><au>Lees, Jennifer S.</au><au>Howie, Katie L.</au><au>Pugh, Dan</au><au>Gillis, Keith A.</au><au>Traynor, Jamie P.</au><au>Macintyre, Iain</au><au>Mark, Patrick B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease</atitle><jtitle>Nephrology (Carlton, Vic.)</jtitle><addtitle>Nephrology (Carlton)</addtitle><date>2021-04</date><risdate>2021</risdate><volume>26</volume><issue>4</issue><spage>328</spage><epage>332</epage><pages>328-332</pages><issn>1320-5358</issn><eissn>1440-1797</eissn><abstract>Recent World Health Organization guidance has aimed to provide pragmatic guidance acknowledging the role of sequential nasopharyngeal swabs taken &gt;24 hours apart for SARS‐CoV‐2 in high‐risk populations. Patients with chronic kidney disease (CKD) are known to have an altered immune milieu which may be associated with a delay in viral clearance. Here, a cross‐sectional observational study of 138 patients admitted with SARS‐CoV‐2 infection at two large regional hospitals in Scotland, UK examined the median time to two consecutive negative nasopharyngeal swabs for SARS‐CoV‐2 in an inpatient population. The median time from admission to the first of two consecutive negative nasopharyngeal swabs was 18 days (range = 1‐44) in patients with CKD, compared with 11 days (range: 1‐71) in patients without CKD (P = .0007). Multivariable linear regression analysis using explanatory variables of age, sex, SARS‐CoV‐2 disease severity, key comorbidities and renal function showed that declining estimated glomerular filtration rate was independently associated with prolonged time to viral clearance. Our data suggest that patients with CKD who are admitted to hospital with SARS‐CoV‐2 take longer to achieve sequential negative nasopharyngeal swab reverse transcription‐polymerase chain reaction results than those without CKD. This has implications for renal service provision, discharge planning and hospital capacity as well as a direct impact on patients due to extended hospital stay, anxiety and stigmatisation. SUMMARY AT A GLANCE In this study, the authors investigated the time between admissions to SARS‐CoV‐2 virus‐negative nasopharyngeal swabs in inpatients. They found that CKD patients had longer time to viral clearance than non‐CKD patients, and concluded that longer CKD patients had longer time to viral clearance, affecting renal service delivery, discharge planning, and admission capacity. In addition, potential anxiety and stigma have a direct impact on the patient.</abstract><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>33368892</pmid><doi>10.1111/nep.13844</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-7709-6595</orcidid><orcidid>https://orcid.org/0000-0003-3387-2123</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1320-5358
ispartof Nephrology (Carlton, Vic.), 2021-04, Vol.26 (4), p.328-332
issn 1320-5358
1440-1797
language eng
recordid cdi_proquest_miscellaneous_2473409771
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
CKD
COVID-19 - complications
COVID-19 - diagnosis
COVID-19 - therapy
COVID-19 Nucleic Acid Testing
Cross-Sectional Studies
Female
Glomerular Filtration Rate
Hospitalization
Humans
Immune clearance
Kidney diseases
Linear Models
Male
Middle Aged
Patients
Polymerase chain reaction
Renal function
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - therapy
Renal Insufficiency, Chronic - virology
Reverse Transcriptase Polymerase Chain Reaction
Reverse transcription
SARS-CoV-2 - physiology
SARS‐CoV‐2
Scotland
Severe acute respiratory syndrome coronavirus 2
Time Factors
viral shedding
Virus Shedding
title Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A05%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20SARS%E2%80%90CoV%E2%80%902%20viral%20shedding%20in%20patients%20with%20chronic%20kidney%20disease&rft.jtitle=Nephrology%20(Carlton,%20Vic.)&rft.au=O'Sullivan,%20Eoin%20D.&rft.date=2021-04&rft.volume=26&rft.issue=4&rft.spage=328&rft.epage=332&rft.pages=328-332&rft.issn=1320-5358&rft.eissn=1440-1797&rft_id=info:doi/10.1111/nep.13844&rft_dat=%3Cproquest_cross%3E2473409771%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2499556578&rft_id=info:pmid/33368892&rfr_iscdi=true